Lipidology - B.S. Lewis
ฝัง
- เผยแพร่เมื่อ 18 ธ.ค. 2024
- Focused round-up of recent, ongoing and upcoming trials in the field of lipidology as related to cardiovascular disease and cardiovascular outcome events.
Includes hot line news regarding new data and directions in trials focused on LDL (statins, PCSK9 inhibitors, PCSK9 synthesis inhibitors, ACL inhibitors, ANGPTL3), HDL and reverse cholesterol transport mechanisms (AEGIS II, epigenetics and apabetalone) and triglycerides (REDUCE IT, PROMINENT).
At the end of the talk the participant will have updated knowledge on clinical trials in the field of lipidology in the primary and secondary prevention of CV disease.